Welcome
RECORD data released, but no final conclusions yet
June 5th, 2007
No definitive answer is forthcoming about the cardiovascular safety of the popular diabetes drug Avandia following the release of preliminary data from the RECORD (Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of glycemia in Diabetes) study. Avandia has been on…more »
Dr. Nissen claiming attack by FDA
May 30th, 2007
An e-mail sent to several health reporters by a top Food and Drug Administration spokesperson appears to be intended to damage the reputation of Dr. Steven Nissen. He is the prominent cardiologist who recently published an important study of the…more »
FDA confirms Avandia heart attack risk
May 26th, 2007
The Food and Drug Administration has confirmed a recent study which concluded that people taking the diabetes drug Avandia have a 43% greater chance of heart attack than those taking a placebo or other such medications.
more »
FDA review confirms Avandia’s heart risks
May 26th, 2007
A study conducted by Dr. David Nissen of the Cleveland Clinic concluded that people taking the diabetes medication Avandia are at a 43% greater risk of heart attack than those taking a placebo or similar drugs. Now comes confirmation from…more »
Discussions begin about Avandia lawsuits
May 24th, 2007
GlaxoSmithKline, maker of the popular diabetes drug Avandia, may soon be facing Avandia lawsuits by a large number of injured patients, according to Avandia lawyers. The company’s total liability in these lawsuits may run into the tens of billions of…more »
Attorneys getting calls about possible Avandia lawsuits
May 24th, 2007
Attorneys examining the case of GlaxoSmithKline’s diabetes drug Avandia say that the company may soon face a flood of Avandia lawsuits by people who were injured or by the families of those who died using the drug.
more »
Debate among experts about NEMJ article and Avandia
May 24th, 2007
The Avandia affair is now moving to Capitol Hill. Senator Charles Grassley has penned a letter to the Food and Drug Administration which says that “tens of thousands of excess heart attacks may have occurred.” He has also written to…more »
UNC doctor informed FDA about Avandia side effects in 2000
May 24th, 2007
Dr. John Buse of the University of North Carolina is president-elect of the American Diabetes Association. Seven years ago, he wrote a letter to the Food and Drug Administration that warned the agency about Avandia side effects and their heart…more »
Doctors, patients ponder Avandia’s future
May 23rd, 2007
Many of the 18 million or so Americans who suffer from type 2 diabetes are unsure what will happen with Avandia, a drug to which they had become accustomed. Avandia, which sensitizes the body to insulin, is not without side…more »
GSK’s settlement of Paxil suit led to Avandia revelations
May 23rd, 2007
Most drug companies are very judicious about the scientific data they give out, emphasizing the positive and downplaying the negative. So why would GlaxoSmithKline post the results of 65 studies that involved its popular diabetes drug Avandia? The data it…more »